PRNewsWire · AMGN · November 11, 2026

AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE

Get the app for more

Explore stock news, insights and company research.